Literature DB >> 8419923

Endothelial cells produce a substance that inhibits contact activation of coagulation by blocking the activation of Hageman factor.

J Kleniewski1, V H Donaldson.   

Abstract

Human umbilical vein endothelial cells (HUVECs) produce a property that impairs the generation of coagulant and amidolytic activity initiated when normal human plasma is exposed to glass. This inhibitory property blocks the adsorption of Hageman factor (factor XII) to glass, thereby preventing the activation of Hageman factor, but does not impair the coagulant or amidolytic activity of already activated Hageman factor (factor XIIa). This property in HUVEC lysates could be neutralized by a purified preparation of Hageman factor but not by purified prekallikrein or high molecular mass kininogen. A partially purified inhibitory fraction from cell lysates exhibited a single homogeneous band in SDS/PAGE of approximately 22.5 kDa. Inhibitory activity was also found in concentrates of conditioned media from HUVECs, which also impaired the binding of Hageman factor to a surface; it may not be identical with that found in cell lysates.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8419923      PMCID: PMC45627          DOI: 10.1073/pnas.90.1.198

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Human plasma prekallikrein: a rapid high-yield method for purification.

Authors:  C F Scott; C Y Liu; R W Colman
Journal:  Eur J Biochem       Date:  1979-10

2.  Prekallikrein deficiency in a kindred with kininogen deficiency and Fitzgerald trait clotting defect. Evidence that high molecular weight kininogen and prekallikrein exist as a complex in normal human plasma.

Authors:  V H Donaldson; J Kleniewski; H Saito; J K Sayed
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

3.  Actin amino-acid sequences. Comparison of actins from calf thymus, bovine brain, and SV40-transformed mouse 3T3 cells with rabbit skeletal muscle actin.

Authors:  J Vandekerckhove; K Weber
Journal:  Eur J Biochem       Date:  1978-10-16

4.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

5.  Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes.

Authors:  E Engvall; P Perlmann
Journal:  J Immunol       Date:  1972-07       Impact factor: 5.422

Review 6.  The biology and pathology of the initial stages of blood coagulation.

Authors:  O D Ratnoff
Journal:  Prog Hematol       Date:  1966

7.  Inhibition of activated factor XII by antithrombin-heparin cofactor.

Authors:  N Stead; A P Kaplan; R D Rosenberg
Journal:  J Biol Chem       Date:  1976-11-10       Impact factor: 5.157

8.  Identification in vitro of an endothelial cell surface cofactor for antithrombin III. Parallel studies with isolated perfused rat hearts and microcarrier cultures of bovine endothelium.

Authors:  C Busch; W G Owen
Journal:  J Clin Invest       Date:  1982-03       Impact factor: 14.808

9.  Human plasma kallikrein. A rapid purification method with high yield.

Authors:  H Nagase; A J Barrett
Journal:  Biochem J       Date:  1981-01-01       Impact factor: 3.857

10.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria.

Authors:  E A Jaffe; R L Nachman; C G Becker; C R Minick
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.